NeuroBo Pharmaceuticals Inc. Common Stock
(NASDAQ:NRBO)
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
NRBO Overview
None
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$0.5100 |
Previous Close Volume |
336300 |